Foamix - Innovative, Versatile Topical Foams with IP protection

Pipeline

About Foamix

Foamix develops innovative topical foam products for dermatology and gynecology. The company partners with global pharmaceutical companies to create patent protected topical products with a variety of drugs including new chemical entities. Advantages of Foamix foam products include increased permeability and drug delivery, convenient form of presentation preferred by users, and enhanced efficacy in clinical studies.

Minocycline Foam

For Impetigo, Acne and Rosacea.

Impetigo Phase II reveals excellent results:

- 80% success on Day 3.

- 100% success on Day 7.

- All MRSA infections were eradicated.

- No drug-related side effects.

Phase II studies for Acne and Rosacea are underway

Recent News

Nov 6

Superior Results in Foamix’s Minocycline Foam Clinical Study. 71% Reduction in Inflammatory Lesions in 6 weeks.